Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(4 sites)
United States
Duke Univerisity, Durham, North Carolina University of Cincinnati, Cincinnati, Ohio Ohio State University, Columbus, Ohio Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah